MGI Tech Co., Ltd. Class A 688114
SSE · China · Health Technology
CNY 71.90+0.31 (+0.43%)
Market closed· · CNY · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · CNY · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Total return, dividends included.
Where the price sits against its 50- and 200-day moving averages.
Makkler Fair Value, financial health score, analyst view, peers and MakklerAI.
MGI Australia, the local Australia and New Zealand team of MGI Tech Co., Ltd. (MGI), has entered a Memorandum of Understanding (MOU) with QIMR Berghofer's National Centre for Spatial Tissue and AI Research (NCSTAR).
[220+ Pages Latest Report] According to a market research study published by Healthcare Foresights, the demand analysis of Global Next Generation Sequencing Services Market size & share revenue was valued at approximately USD 6.8 Billion in 2025 and is expected to reach USD 8.3 Billion in 2026 and is expected to reach around USD 56.1 Billion by 2035, at a CAGR of 23.5% between 2026 and 2035. The key market players listed in the report with their sales, revenues and strategies are Illumina Inc.,
MGI Tech Co., Ltd. (MGI), a company dedicated to developing core tools and technologies that drive innovation in life sciences, celebrates its 10th anniversary, a decade marked by breakthroughs that have helped transform genomics into a scalable, data-driven and accessible engine of discovery.
Recent third-party headlines about this company, kept separate from Makkler's own editorial coverage and linking out to the publisher. Accuracy is the publisher's responsibility.